Cardiology
Creating a patient oriented approach to optimal and lifelong cardiovascular care through science, ranging from prevention to treatment, in order to reduce the burden of cardiovascular disease.
Research Activities
The department of cardiology invests in a range of research domains incorporating very different parts of the cardiovascular system from vascular diseases, valvular dysfunction, conduction and rhythm abnormalities, sex and gender differences up to cardiac functional disorders, with a specific focus on the aorta, hypertension, physiologic pacing, myocardial function, valvular regurgitation and pulmonary hypertension.
Research Staff
- Prof. dr. Julie De Backer: aortic disease and (adult) congenital heart disease
- Prof. dr. Tine De Backer: hypertension and vascular disease; cardiovascular and metabolic disorders in transgenders;
- Prof. dr. Michel De Pauw: pulmonary hypertension
- Prof. dr. Jan De Pooter: cardiac conduction disturbances and physiologic pacing
- Prof. dr. Sofie Gevaert: hypertension and vascular disease; cardiovascular conduction disturbances and physiologic pacing
- Prof. dr. Peter Gheeraert: cardiology and cardiovascular medicine
- Prof. dr. Frank Timmermans: cardiac conduction disturbances and physiological pacing; valvular heart disease
- Prof. dr. Ernst Rietzschel: cardiovascular and metabolic disorders in transgenders
Research Themes
Aortic Disease and (Adult) Congenital Heart Disease
- Developing a platform for precision medicine in Heritable Thoracic Aortic Disease: through integration of basic science (mouse and zebrafish models) and human data we aim to identify better strategies for risk stratification and treatment.
- Transition in cardiology : develop an evidence-based transition project, which has a positive impact on disease-related knowledge, quality of life, transition experience and continuity of care.
- Precision medicine in childhood-onset diseases: A lifespan perspective on accelerated aging in congenital heart disease using the epigenetic clock.
Hypertension and Vascular Disease
- Hypertension accurate diagnosis, optimal management & new therapies, in collaboration with Belgian Society of Hypertension and European Society of Hypertension.
- Fibromuscular dysplasia & spontaneaous coronary dissection (FMD & SCAD) diagnosis, management and follow up; in collaboration with several departments in UZ Ghent and several other centres in Belgium & Europe & worldwide.
- Anticoagulation optimal management, in collaboration with Faculty of Pharmaceutical Sciences.
- Cardiovascular screening and Diabetes mellitus in collaboration with Endocrinology and Revalidation & Kinesitherapy.
- Cardiovascular and metabolic disorders in transgenders
ENIGI: exploring interaction between hormonal and genderrole related factors in transgender men and women, a collaborative project with the department of Endocrinology.
Cardiac Conduction Disturbances and Physiologic Pacing
- Our research group investigates the electrocardiographic and echocardiographic characteristics of left bundle branch block, and investigates the pathophysiology of left bundle branch block in the context of heart failure and cardiac resynchronization therapy. In particular, we analyse the impact of left bundle branch block on left ventricular remodeling in heart failure patients to allow risk stratification and treatment strategy.
- We aim to optimize current pacing strategies for individual patients and contributes to the development of new and innovative pacing modalities. The focus of this research is to obtain physiologic pacing with preservation of normal cardiac contraction during pacing. The electrophysiologic department of the University Hospital Ghent is a pioneer in the field of conduction system pacing with an excellent international reputation in the field of physiologic pacing.
Valvular Heart Disease
Our group has developed a novel echocardiographic grading method for mitral valve regurgitation that allows improved grading, risk stratification and decision making in mitral valve regurgitation.
Pulmonary Hypertension
Study and development of early diagnosis and treatment of PAH in systemic sclerosis and porto- pulmonary hypertension in collaboration with the departments of rheumatology.